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Toll-like receptors (TLRs) have evolved to recognize lipoproteins from diverse species of bacteria. In this
issue of Immunity, Kang et al. (2009) provide insight into the mechanisms by which TLR2-TLR6 heterodimers
recognize diacylated liporoteins, whereas TLR2-TLR1 heterodimers recognize triacylated lipopeptides.The posttranslational modification of pro-
teins in bacteria, to form diacylated or
triacylated lipoproteins, provides a mech-
anism by which proteins are directed,
transported, and anchored into the bacte-
rial cell membranes and outer envelopes.
The localization of lipoproteins into
either the inner or outer membranes of
bacteria is pivotal to their function in
a variety of cellular processes including
structural integrity, transport, sensing,
adhesion, and signal transduction. The
host innate immune response, in contrast,
has evolved to recognize these lipopro-
teins, which have distinct structures in
diverse bacterial species. In this issue of
Immunity, Kang et al. (2009) provide new
insight into the mechanisms by which
receptors of the innate immune system
distinguish the fatty acid moieties of
bacterial lipoproteins.
Bacterial proteins are targeted for acyl-
ation via a conserved N-terminal signal
sequence that terminates with a ‘‘lipo-
box,’’ [LVI]-[AST]-[GA]-C, which is recog-
nized by the three conserved enzymes
responsible for the posttranslational lipid
modification (Hutchings et al., 2009) (Fig-
ure 1). First, a prolipoprotein diacylglycer-
yltransferase (Lgt) transfers a diacylgly-
ceride moiety from the phospholipid pool
to the cysteine sulfhydryl group of the lipid
box via a thioester linkage. Second, the
signal peptide is cleaved just before
the cysteine residue. These modifications
result in the synthesis of diacylated
lipoproteins in Gram-positive and Gram-
negative bacteria, as well as in acid-fast
bacteria including mycobacteria. The
acylation of bacterial proteins facilitates
anchoring in the bacterial cytoplasmicmembrane. The third step, which occurs
in Gram-negative and acid-fast bacteria,
but is absent in Mycoplasma spp and
some Gram-positive bacteria, involves
an apolipoprotein N-acyltransferase (Lnt)
that adds a third fatty acid to the amino
group of the N-terminal cysteine. The
triacylation of proteins in Gram-negative
organisms facilitates transport of the lipo-
protein to the outer membrane via the
lipoprotein localization (Lol) pathway.
The ability of the bacterial pathogens to
produce two forms of lipoproteins, diacy-
lated and triacylated, creates a diversity
in biochemical patterns and hence a
challenge for recognition by the innate
immune system. Work from our lab
(Brightbill et al., 1999) and others (Alipran-
tis et al., 1999) led to the discovery that
the human innate immune system recog-
nizes bacterial lipoproteins via Toll-like
receptor 2 (TLR2). Further investigation
revealed that TLR2 is able to recognize
the bacterial lipoproteins that are either
diacylated or triacylated by forming heter-
odimers with TLR6 or TLR1, respectively
(Takeuchi et al., 2002).
In this issue of Immunity, Kang et al.
describe the crystal structure of the TLR2-
TLR6-diacylated lipopeptide complex
(Kang et al., 2009), which together with
previous papers on the TLR2-TLR1-tria-
cylated lipopeptide complex (Jin et al.,
2007), provides new insight into the
mechanism by which TLR2 looks at lipo-
proteins. Specifically, the ability of TLR2
to heterodimerize with either TLR6 or
TLR1 results in the formation of distinct
binding pockets which facilitate the rec-
ognition of diacylated and triacylated
lipopeptides, respectively. A key featureImmunity 31, Dof TLRs is the leucine-rich repeat (LRR)
domains, which contribute to recognition
of microbial ligands. The major driving
force for TLR2 binding of lipopeptides is
a strong but relatively nonspecific hydro-
phobic interaction between ester-bound
fatty acids and the internal pocket formed
by hydrophobic residues from the LRR9-
12 modules. There is a minimal require-
ment of diacylated lipopeptides for TLR2
recognition, and subsequent induction of
a robust response requires that the lipo-
peptide have two acyl chains of at least
12 carbons each (eight for mouse TLR2)
(Buwitt-Beckmann et al., 2006). TLR2-
TLR1 recognition of triacylated lipopepti-
des and heterodimer formation requires
the interaction between a fatty acid of at
least eight carbons in length that is amide
linked on the N-terminal cysteine of the
lipopeptide and a hydrophobic channel
present in the LRR module of TLR1
(Figure 1). For TLR6, this hydrophobic
channel is blocked by two phenylalanine
residues, F343 and F365 (Figure 1). A
mutant TLR6, in which F343 and F365
were replaced with less bulky methionine
and lysine amino acids found in TLR1,
was able to form a complex with TLR2
and triacylated lipopeptides and trans-
duce an immunological response.
Unlike the TLR2-TLR1 heterodimer
formation, in which fatty acid moieties
were bound to each TLR in the complex,
Kang et al. (2009) demonstrate that TLR2-
TLR6 heterodimer formation depends on
hydrogen bonds between glycerol and
the peptide backbone of the ligand and
the LRR11 loops of TLRs. These hydro-
gen bonds simultaneously interact with
the ligand and bridge TLR2 and TLR6,ecember 18, 2009 ª2009 Elsevier Inc. 847
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Figure 1. TLR2 Recognition and Response to Bacterial Lipoproteins
Bacterial proteins are targeted for acylation at an N-terminus cysteine. In Gram-positive bacteria and
mycoplasma, the result is diacylation, whereas in Gram-negative bacteria and mycobacteria, the result
is triacylation. TLR2 forms ‘‘m’’-shaped heterodimers with either TLR6 or TLR1, with the diacyl moiety
bound by TLR2. TLR1 has a hydrophobic channel that binds to the third acyl function such that TLR2-
TLR1 heterodimers bind to triacylated lipoproteins. This hydrophobic channel is closed off in TLR6 by
the presence of phenylalanines at positions 343 and 365, such that TLR2-TLR6 heterodimers bind diacy-
lated lipoproteins. Both TLR2-TLR6 and TLR2-TLR1 induce the same signaling cascade via MyD88 result-
ing in activation of NF-kB and subsequent induction of innate immune functions including the release of
cytokines to instruct the adaptive immune response, phagocytosis, and antimicrobial responses.
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phobic residues in the center of the dimer-
ization interface. Therefore, the entire
lipopeptide—the fatty acids and the pep-
tide head group—is responsible for the
specificity of the interaction in the forma-
tion of TLR2-TLR6 heterodimers (Buwitt-
Beckmann et al., 2006).
Kang et al. (2009) provide compelling
evidence that the side chains of the first
two amino acids of diacylated lipopepti-
des have substantial interactions with
the TLRs. The amino-terminal cysteine848 Immunity 31, December 18, 2009 ª2009binds to the ‘‘sulfur site’’ formed by the
hydrophobic F325, L328, F349, L350,
and P325 residues of TLR2 and the L318
residue of TLR6. An amino acid with
a small R group side chain such as serine
is preferred as the second residue, so that
it can fit into the narrow neck area of the
ligand-binding pocket generated by the
LRR11 loops of TLR2 and TLR6 and
form a hydrogen bond with the F325 on
the backbone of TLR2. Although studies
with defined lipopeptides indicate that
the amino acids directly adjacent to theElsevier Inc.diacylglycerol can affect their potency in
activating TLR2-dependent responses, it
must be recognized that during natural
infections, it is lipoproteins with long poly-
peptide chains and not lipopeptides that
activate the TLR2-TLR1 and TLR2-TLR6
dimers. Some studies indicate that native
lipoproteins are more potent inducers of
TLR2 responses than synthetic lipopepti-
des, suggesting the possibility that down-
stream amino acids of certain lipoproteins
interact with the extensive LRR domains
of the TLRs.
The ability of cell-surface TLR2 to form
heterodimers with TLR1 and TLR6 is not
the only mechanism by which the innate
immune system recognizes the biochem-
ical diversity between Gram-positive
and Gram-negative bacteria. The closely
related cytosolic receptors NOD1 and
NOD2 distinguish structures in bacterial
cell walls, specifically peptidoglycan
motifs. An important difference between
Gram-positive and Gram-negative pepti-
doglycan is the nature of the third amino
acid in the peptidoglycan stem peptide
motif. A diaminopimelic acid (DAP) is
found in the peptidoglycan motif of
most Gram-negative bacteria, such that
the naturally occurring peptidoglycan
degradation product sensed by NOD1
is GlcNAc-MurNAc-L-Ala- D-Glu-meso-
DAP (GM-triDAP) (Girardin et al., 2003).
The recognition of these products by
NOD1 is dependent on the presence of
an exposed meso-DAP, an amino acid
absent from eukaryotes, representing a
very simple signature of bacterial origin.
In contrast, the minimal motif recognized
by NOD2 is the muramyl dipeptide Mur-
NAc-L-Ala-D-isoGln (MDP), present in
Gram-positive and Gram-negative and
mycobacterial peptidoglycans (Girardin
et al., 2003). However, NOD2 also recog-
nize a muramyl tripeptide in which the
third amino acid position is occupied
by one of the amino acids specific to
Gram-positive peptidoglycan (L-lysine or
L-ornithine) (Girardin et al., 2003). The
distinct locations of TLRs and NLRs in
cellular compartments and/or cell sub-
sets provide an important mechanism
of regulating innate immune responses
and the outcome of an infection. Further-
more, simultaneous activation of TLRs
by lipoproteins and NOD proteins by
peptidoglycan results in a synergistic
antibacterial response. Although TLR2-
TLR6 versus TLR2-TLR1 and NOD1
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Previewsversus NOD2 allow the innate immune
system to recognize biochemical differ-
ences between Gram-positive and Gram-
negative bacteria, several other innate
receptors recognize conserved motifs,
e.g., DNA by TLR9 and RNA by RIG-I heli-
case.
The capacity of the innate immune
system to distinguish biochemical differ-
ences between Gram-positive and Gram-
negative bacteria does not appear to
result in distinct functional responses.
Activation of TLR2-TLR1 and TLR2-
TLR6 induces innate immune pathways
required for host defense against micro-
bial pathogens including cytokine release
and dendritic cell and macrophage differ-
entiation (Krutzik et al., 2005), as well as
microbicidal activity (Liu et al., 2006)
(Figure 1). Therefore, the function of the
different TLR2 heterodimers is to enable
recognition of bacteria with different cell
envelopes, but that once triggered, the
immunologic mechanisms appear to acti-
vate the same pathways. The elegant
recognition mechanisms by which TLRs
can distinguish lipoproteins provides a
new impetus to search for differences in
the subsequent innate immune response.
The ability of TLR2 to mediate the
recognition and immune response to
various nonpeptide ligands, including
lipoteichoic acid, is still controversial
and thought by some to be the result ofcontamination of preparations with lipo-
proteins, as extensively discussed by
Kang et al. in the Supplemental Data
(Kang et al., 2009). Nevertheless, Kang
et al. provide evidence that lipoteichoic
acid from Streptococcus pneumoniae
binds to TLR2, with the lipid chains in-
serted into the TLR2 hydrophobic pocket.
They also provide evidence that the polar
head groups of TLR2 ligands are critical
for heterodimer formation. These studies
indicate that such nonpeptide ligands
can bind to TLR2 but do not resolve
the issue as to whether they, under
physiologic conditions, activate cellular
responses. Clearly, more research into
this area is warranted to define the
universe of natural TLR2 ligands that can
trigger host innate immune responses.
In summary, the innate immune system
is encoded to distinguish biochemical
differences between Gram-positive and
Gram-negative bacteria. In particular, the
laboratory of Jie-Oh Lee has provided
clear evidence that TLR2 has 20/20 vision
for lipoproteins, the heterodimerization of
TLR2-TLR1 and TLR2-TLR6 heterodimers
forms different lipid-binding pockets that
distinguish triacylated from diacylated
lipopeptides (Jin et al., 2007; Kang et al.,
2009). Although TLR2 has perfect vision
to distinguish distinct lipoproteins, the
subsequent immune responses appear
to be identical carbon copies.Immunity 31, DREFERENCES
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The ability of a single T cell to recognize the diverse peptides it encounters is based on T cell receptor
crossreactivity. In this issue of Immunity, Macdonald et al. (2009) and Borbulevych et al. (2009) provide
new insights into the structural principles underlying this fundamental property of T cells.Given the vast numbers of clonotypically
unique T cell receptors (TCRs) that can
be generated by combinatorial diversifi-cation and imprecise joining of gene
segments, it was initially believed that
the immune system might be capable ofgenerating a unique TCR for almost every
antigenic peptide. However, subsequent
estimates of the peptide repertoireecember 18, 2009 ª2009 Elsevier Inc. 849
